Medscape4d
Single-Dose Intravenous Salbutamol Bolus for Managing Children With Acute Severe Asthma in the Emergency Department: Reanalysis of Data
The administration of salbutamol was accompanied with 5 mg/kg intravenous hydrocortisone as a bolus administered over 3 mins immediately followed by an infusion of the study drug administered over ...
Medscape6d
Single-Dose Intravenous Salbutamol Bolus for Managing Children With Acute Severe Asthma in the Emergency Department: Reanalysis of Data
As shown in Table 1, there was no difference in the mean age, distribution of male and female patients, mean weight, and the presenting Pulmonary Index Score between the two control groups of the ...
Daily4d
Perioperative IV infusion of lidocaine fails to improve return of gut function after elective minimally invasive colon resection: JAMA
Perioperative IV infusion of lidocaine fails to improve return of gut function after elective minimally invasive colon ...
jnis.bmj5d
Half bolus dose of intravenous abciximab is safe and effective in the setting of acute stroke endovascular treatment
The aim of this study was to evaluate the incidence of symptomatic intracerebral hematoma (sICH) associated with our antiplatelet protocol: intravenous abciximab bolus at half the dose (0125 mg/kg) at ...
rheumatologyadvisor6d
Few Patients Achieve Sustained Drug-Free Remission in Giant Cell Arteritis
Achievement of sustained drug-free remission in GCA is rare; relapses and the need for GC boluses were associated with requiring long-term GC treatment.
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal ...
Amgen: FDA Approves Lumakras (sotorasib) In Combination With Vectibix (panitumumab) For Chemorefractory Kras G12c-mutated Metastatic Colorectal Cancer
Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...